Posted in | News | Laser | Imaging

Senscient Earns ATEX Certification for its New ELDS Gas Detectors

Senscient today received ATEX International Certification from FM Approvals Ltd. for operation of their new Open Path Gas Detector (OPGD) ELDS 1000 Series for methane and ELDS 2000 Dual Gas Series for methane and hydrogen sulfide in potentially explosive atmospheres.

Open Path Gas Detector ELDS

With features that include 3x better sensitivity for detecting flammable gases and lower ppm level toxic gases, Senscient ELDS open path gas detectors offer facility owners a substantial improvement in site safety and risk management over previous NDIR-based technology systems. Additionally, the ELDS 2000 Series OPGD is the first fixed gas detector able to monitor both methane and hydrogen sulfide in a single unit simultaneously with discreet output communication.

Senscient's patented Enhanced Laser Diode Spectroscopy (ELDS) solves major problems associated with traditional fixed gas detectors by eliminating routine re-calibration, sensor replacement, unreliable readings and false alarms that cost industries millions of dollars in lost revenue annually.

ELDS is designed to provide new levels of plant safety and risk reduction in offshore platforms, FPSOs, onshore petrochemical facilities and refineries. New ELDS units targeting other industries and gas hazards are being introduced throughout 2010.

The ATEX certification ensures Senscient ELDS Series 1000 and 2000 open path gas detectors are capable of detecting the target gas over an entire line of sight coverage of 5 to 40 meters. The certification also confirms the systems' ability to trigger isolated multi-channel analogue or digital output signals to a remote safety PLC.

"ATEX Directive 94/9/EC is the final Senscient ELDS certification required for us to meet our goal to become the first fixed gas detector manufacturer to meet all performance-based hazardous area compliant product and facility standards for USA, Canada, and Europe," according to Jean Berthold, Senscient CMSO and VP.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.